The impact of a new reference value set for diffusing capacity for patients with idiopathic pulmonary fibrosis.

M. Wapenaar - De Korver (Rotterdam, Netherlands), J. Miedema (Rotterdam, Netherlands), C. Lammering (Rotterdam, Netherlands), M. Wijsenbeek (Rotterdam, Netherlands)

Source: International Congress 2018 – Quality, reference values and standards
Session: Quality, reference values and standards
Session type: Oral Presentation
Number: 3779
Disease area: Interstitial lung diseases

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Wapenaar - De Korver (Rotterdam, Netherlands), J. Miedema (Rotterdam, Netherlands), C. Lammering (Rotterdam, Netherlands), M. Wijsenbeek (Rotterdam, Netherlands). The impact of a new reference value set for diffusing capacity for patients with idiopathic pulmonary fibrosis.. 3779

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Can clinical data predict rapid decline of lung function in idiopathic pulmonary fibrosis (IPF) patients?
Source: International Congress 2017 – IPF: from the bench to the bedside
Year: 2017

The impact of a network based approach on lung function and symptom duration at diagnosis in idiopathic pulmonary fibrosis
Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia
Year: 2018


Association between diffusion capacity and endothelial function in patients with idiopathic pulmonary fibrosis
Source: International Congress 2018 – Sarcoidosis, interstitial lung diseases and various clinical problems
Year: 2018

Exercise limitation in patients with interstitial lung disease independent from diffusion capacity (DLCO)
Source: Annual Congress 2008 - Exercise: system responses
Year: 2008


Prognostic value of modified classification based on lung function tests in idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2006; 28: Suppl. 50, 827s
Year: 2006

Changing the idiopathic pulmonary fibrosis treatment approach and improving patient outcomes
Source: Eur Respir Rev 2012; 21: 161-167
Year: 2012



Does the questionnaire “human activity profile” assess functional capacity in patients with idiopathic pulmonary fibrosis?
Source: Virtual Congress 2021 – News in treatment and diagnosis of idiopathic interstitial pneumonia
Year: 2021


Analysis of patients with idiopathic pulmonary fibrosis (IPF) with percent predicted forced vital capacity (FVC)<50% treated with pirfenidone (PFD) in RECAP
Source: International Congress 2016 – IPF treatment I
Year: 2016



Early decrease of forced vital capacity is a good prediction tool for prognosis in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Year: 2008

The impact of idiopathic pulmonary fibrosis on the airway length per generation in the human lung
Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia
Year: 2021


Does daily physical activity levels or functional exercise capacity provide additional prognostic information in idiopathic pulmonary fibrosis (IPF)?
Source: International Congress 2019 – Hot topics in pulmonary rehabilitation
Year: 2019

The predictive value of inspiratory fraction to exercise capacity in patients with stable moderate to severe chronic obstructive pulmonary disease
Source: Annual Congress 2012 - New issues in pulmonary function
Year: 2012

Novel CT markers of volume loss in idiopathic pulmonary fibrosis (IPF) predict mortality
Source: International Congress 2017 – Novel imaging findings characterising various lung diseases and their prognoses
Year: 2017



Analysis of pulmonary function in patients with idiopathic pulmonary fibrosis (IPF): how stable is stable IPF?
Source: Annual Congress 2009 - A wide spectrum of idiopathic pulmonary fibrosis
Year: 2009


Functional and prognostic significance of relationship between VC and TLC in patients with idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2005; 26: Suppl. 49, 334s
Year: 2005

Serum surfactant protein D (SP-D) and annual decline of diffusion capacity are prognostic factors for combined pulmonary fibrosis with emphysema (CPFE) in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2013 –Clinical respiratory physiology in different diseases
Year: 2013


Forced vital capacity, total lung capacity and diffusion capacity in idiopathic pulmonary fibrosis
Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries
Year: 2018




Titrated oxygen requirement and prognostication in idiopathic pulmonary fibrosis
Source: Eur Respir J 2012; 39: 359-365
Year: 2012



Is there a relationship between quality of life and exercise performance in idiopathic pulmonary fibrosis (IPF)?
Source: Eur Respir J 2007; 30: Suppl. 51, 577s
Year: 2007